Bellevue Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
20,906
+5,356
| +34% | +$338K | 0.03% | 102 |
|
|
2025
Q1 | $824K | Sell |
15,550
-8,046
| -34% | -$426K | 0.02% | 110 |
|
|
2024
Q4 | $1.32M | Buy |
23,596
+7,896
| +50% | +$442K | 0.03% | 113 |
|
|
2024
Q3 | $823K | Buy |
15,700
+2,700
| +21% | +$141K | 0.01% | 123 |
|
|
2024
Q2 | $534K | Buy |
13,000
+500
| +4% | +$20.5K | 0.01% | 127 |
|
|
2024
Q1 | $542K | Sell |
12,500
-20,369
| -62% | -$883K | 0.01% | 128 |
|
|
2023
Q4 | $1.51M | Sell |
32,869
-40,431
| -55% | -$1.86M | 0.02% | 114 |
|
|
2023
Q3 | $1.68M | Buy |
+73,300
| New | +$1.68M | 0.03% | 115 |
|